Technical Analysis for BHC - Bausch Health Companies Inc.

Grade Last Price % Change Price Change
grade B 24.23 -3.31% -0.83
BHC closed down 3.31 percent on Monday, May 20, 2019, on approximately normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical BHC trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Fell Below 50 DMA Bearish 0.00%
Down 3 Days in a Row Weakness 0.00%
Narrow Range Bar Range Contraction -4.00%
NR7 Range Contraction -4.00%
50 DMA Support Bullish -4.15%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -4.15%
Outside Day Range Expansion -4.15%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -2.81%
Calm After Storm Range Contraction -2.81%

Older signals for BHC ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Bausch Health Companies Inc, formerly Valeant Pharmaceuticals International Inc, is a Canada-based company that develops, manufactures and markets a range of branded and generic pharmaceuticals, medical devices and over-the-counter products. It primarily develops products in the therapeutic areas of eye health, gastroenterology and dermatology. Its dermatology products treat a range of conditions, including actinic keratosis, acne, atopic dermatitis, psoriasis and other dermatoses. It also offers a selection of aesthetic medical devices that address a variety of conditions, including facial wrinkles, acne, pigmentation conditions and laser hair removal, among others. The gastrointestinal (GI) segment offers products that treat GI and hepatologic conditions, including hepatic encephalopathy, irritable bowel syndrome with diarrhea and ulcerative colitis, among others. Its eye health products are marketed in the following categories: Contact Lens, Pharmaceutical Products and Surgical.
Biotechnology Life Sciences Laser Organ Systems S&P/Tsx 60 Index Psoriasis Medical Devices Acne Specialty Drugs Ulcerative Colitis Atopic Dermatitis Diarrhea Irritable Bowel Syndrome Hair Removal Generic Pharmaceuticals Over The Counter Products Salix Pharmaceuticals Bausch Health Eye Health Products
Is BHC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 28.45
52 Week Low 17.2
Average Volume 3,680,418
200-Day Moving Average 23.772
50-Day Moving Average 24.5474
20-Day Moving Average 24.4285
10-Day Moving Average 25.266
Average True Range 0.8801
ADX 15.33
+DI 21.4039
-DI 24.9513
Chandelier Exit (Long, 3 ATRs ) 24.1497
Chandelier Exit (Short, 3 ATRs ) 25.2003
Upper Bollinger Band 26.564
Lower Bollinger Band 22.293
Percent B (%b) 0.45
BandWidth 17.483677
MACD Line 0.1932
MACD Signal Line 0.1837
MACD Histogram 0.0095
Fundamentals Value
Market Cap 8.45 Billion
Num Shares 349 Million
EPS -3.27
Price-to-Earnings (P/E) Ratio -7.41
Price-to-Sales 0.44
Price-to-Book 1.03
PEG Ratio -0.33
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 25.55
Resistance 3 (R3) 25.66 25.33 25.33
Resistance 2 (R2) 25.33 24.99 25.28 25.26
Resistance 1 (R1) 24.78 24.79 24.62 24.67 25.18
Pivot Point 24.45 24.45 24.37 24.40 24.45
Support 1 (S1) 23.90 24.11 23.74 23.79 23.28
Support 2 (S2) 23.57 23.91 23.52 23.20
Support 3 (S3) 23.02 23.57 23.13
Support 4 (S4) 22.91